These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14767515)

  • 1. Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
    Reinecke P; Steckstor M; Schmitz M; Gabbert HE; Gerharz CD
    Oncol Rep; 2004 Mar; 11(3):641-5. PubMed ID: 14767515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
    Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
    Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
    J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Reinecke P; Knopf C; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer; 2000 Apr; 88(7):1614-22. PubMed ID: 10738220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
    Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N
    Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
    Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S
    Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.
    Webster L; Linsenmeyer M; Millward M; Morton C; Bishop J; Woodcock D
    J Natl Cancer Inst; 1993 Oct; 85(20):1685-90. PubMed ID: 8105099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.
    Kanzaki A; Takebayashi Y; Ren XQ; Miyashita H; Mori S; Akiyama S; Pommier Y
    Mol Cancer Ther; 2002 Dec; 1(14):1327-34. PubMed ID: 12516966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
    Yuan F; Liu J; Qiao T; Li T; Shen Q; Peng F
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27367657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
    Kusakabe H; Iwasaki H; Sano K; Kiyokane K
    Arch Dermatol Res; 2000 Jun; 292(6):292-300. PubMed ID: 10929770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-induced cytotoxicity--the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein.
    Fjällskog ML; Frii L; Bergh J
    Eur J Cancer; 1994; 30A(5):687-90. PubMed ID: 7915908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
    Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
    Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance reversal activity of taxoids from Taxus cuspidata in KB-C2 and 2780AD cells.
    Kobayashi J; Shigemori H; Hosoyama H; Chen Z; Akiyama S; Naito M; Tsuruo T
    Jpn J Cancer Res; 2000 Jun; 91(6):638-42. PubMed ID: 10874217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
    Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
    Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.